BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14602201)

  • 1. Induction of FAS ligand expression in a human hepatoblastoma cell line by HCV core protein.
    Ruggieri A; Murdolo M; Rapicetta M
    Virus Res; 2003 Nov; 97(2):103-10. PubMed ID: 14602201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.
    Yoo YG; Lee MO
    J Biol Chem; 2004 Aug; 279(35):36242-9. PubMed ID: 15173177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Death of solid tumor cells induced by Fas ligand expressing primary myoblasts.
    Hofmann A; Blau HM
    Somat Cell Mol Genet; 1997 Jul; 23(4):249-57. PubMed ID: 9542527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells.
    Asanuma K; Tsuji N; Endoh T; Yagihashi A; Watanabe N
    J Immunol; 2004 Mar; 172(6):3922-9. PubMed ID: 15004200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
    Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic action of protein kinase C theta and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells.
    Villunger A; Ghaffari-Tabrizi N; Tinhofer I; Krumböck N; Bauer B; Schneider T; Kasibhatla S; Greil R; Baier-Bitterlich G; Uberall F; Green DR; Baier G
    Eur J Immunol; 1999 Nov; 29(11):3549-61. PubMed ID: 10556809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of FasL expression in tumor cells and preventing tumor necrosis factor-induced apoptosis by adenovirus 14.7K is an effective escape mechanism for immune cells.
    Zhang J; Xu G
    Cancer Genet Cytogenet; 2007 Dec; 179(2):112-7. PubMed ID: 18036397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-terminal region of hepatitis C core protein is required for Fas-ligand independent apoptosis in Jurkat cells by facilitating Fas oligomerization.
    Moorman JP; Prayther D; McVay D; Hahn YS; Hahn CS
    Virology; 2003 Aug; 312(2):320-9. PubMed ID: 12919737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival.
    Xu G; Zhang J
    J Cancer Res Clin Oncol; 2008 Oct; 134(10):1043-9. PubMed ID: 18461366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection of apoptosis related gene Fas ligand in human hepatocellular carcinoma cells and its significance in apoptosis.
    Chen J; Su XS; Jiang YF; Gong GZ; Zheng YH; Li GY
    World J Gastroenterol; 2005 May; 11(17):2653-5. PubMed ID: 15849828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Fas ligand expression of CD4+ T cells by HCV core induces T cell-dependent hepatic inflammation.
    Cruise MW; Melief HM; Lukens J; Soguero C; Hahn YS
    J Leukoc Biol; 2005 Aug; 78(2):412-25. PubMed ID: 15894587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
    Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of fas ligand in human hepatoma cell lines: role of hepatitis-B virus X (HBX) in induction of Fas ligand.
    Shin EC; Shin JS; Park JH; Kim H; Kim SJ
    Int J Cancer; 1999 Aug; 82(4):587-91. PubMed ID: 10404075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand.
    von Bernstorff W; Spanjaard RA; Chan AK; Lockhart DC; Sadanaga N; Wood I; Peiper M; Goedegebuure PS; Eberlein TJ
    Surgery; 1999 Jan; 125(1):73-84. PubMed ID: 9889801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Sp1 binding site involves the transcription of the Fas ligand gene induced by PMA and ionomycin in Jurkat cells.
    Chou CF; Peng HW; Wang CY; Yang YT; Han SH
    J Biomed Sci; 2000; 7(2):136-43. PubMed ID: 10754388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction.
    Iken K; Huang L; Bekele H; Schmidt EV; Koziel MJ
    Virology; 2006 Mar; 346(2):363-72. PubMed ID: 16336987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of specific antisense oligonucleotide inhibition of Fas expression on T cell apoptosis induced by Fas ligand.
    Mao H; Liu Q; Zhang J; Gu H; Wang L; Zhou X; Yin H; Zhang L; Xie F; Jiang G
    Int Immunopharmacol; 2007 Dec; 7(13):1714-22. PubMed ID: 17996681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter.
    Faris M; Latinis KM; Kempiak SJ; Koretzky GA; Nel A
    Mol Cell Biol; 1998 Sep; 18(9):5414-24. PubMed ID: 9710625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle perturbation in a human hepatoblastoma cell line constitutively expressing Hepatitis C virus core protein.
    Ruggieri A; Murdolo M; Harada T; Miyamura T; Rapicetta M
    Arch Virol; 2004 Jan; 149(1):61-74. PubMed ID: 14689276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.